These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25038562)

  • 41. Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons.
    Mosharov EV; Larsen KE; Kanter E; Phillips KA; Wilson K; Schmitz Y; Krantz DE; Kobayashi K; Edwards RH; Sulzer D
    Neuron; 2009 Apr; 62(2):218-29. PubMed ID: 19409267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
    Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
    Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective increase of in vivo firing frequencies in DA SN neurons after proteasome inhibition in the ventral midbrain.
    Subramaniam M; Kern B; Vogel S; Klose V; Schneider G; Roeper J
    Eur J Neurosci; 2014 Sep; 40(6):2898-909. PubMed ID: 25059097
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Failure of estrogen to protect the substantia nigra pars compacta of female rats from lesion induced by 6-hydroxydopamine.
    Ferraz AC; Xavier LL; Hernandes S; Sulzbach M; Viola GG; Anselmo-Franci JA; Achaval M; Da Cunha C
    Brain Res; 2003 Oct; 986(1-2):200-5. PubMed ID: 12965246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carbachol induces burst firing of dopamine cells in the ventral tegmental area by promoting calcium entry through L-type channels in the rat.
    Zhang L; Liu Y; Chen X
    J Physiol; 2005 Oct; 568(Pt 2):469-81. PubMed ID: 16081481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Organotypic vibrosections: novel whole sagittal brain cultures.
    Ullrich C; Daschil N; Humpel C
    J Neurosci Methods; 2011 Sep; 201(1):131-41. PubMed ID: 21835204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY; Lee JE; Park JH; Shin IC; Koh HC
    Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.
    Salama M; Ellaithy A; Helmy B; El-Gamal M; Tantawy D; Mohamed M; Sheashaa H; Sobh M; Arias-Carrión O
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):836-43. PubMed ID: 23198691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NMDA alters rotenone toxicity in rat substantia nigra zona compacta and ventral tegmental area dopamine neurons.
    Munhall AC; Wu YN; Belknap JK; Meshul CK; Johnson SW
    Neurotoxicology; 2012 Jun; 33(3):429-35. PubMed ID: 22521663
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peculiar effects of isradipine and darodipine on the rat brain dopaminergic system.
    Gaggi R; Dall'Olio R; Roncada P; Gianni AM
    Gen Pharmacol; 1995 Mar; 26(2):303-8. PubMed ID: 7590078
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nimodipine Exerts Time-Dependent Neuroprotective Effect after Excitotoxical Damage in Organotypic Slice Cultures.
    Hohmann U; Ghadban C; Hohmann T; Kleine J; Schmidt M; Scheller C; Strauss C; Dehghani F
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective effect of L-type calcium channel blockers against haloperidol-induced orofacial dyskinesia: a behavioural, biochemical and neurochemical study.
    Bishnoi M; Chopra K; Kulkarni SK
    Neurochem Res; 2008 Sep; 33(9):1869-80. PubMed ID: 18363098
    [TBL] [Abstract][Full Text] [Related]  

  • 53. GDNF increases the density of cells containing calbindin but not of cells containing calretinin in cultured rat and human fetal nigral tissue.
    Meyer M; Zimmer J; Seiler RW; Widmer HR
    Cell Transplant; 1999; 8(1):25-36. PubMed ID: 10338273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture.
    Chan WS; Durairajan SS; Lu JH; Wang Y; Xie LX; Kum WF; Koo I; Yung KK; Li M
    Neurochem Int; 2009 Nov; 55(6):414-22. PubMed ID: 19409437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The immunophilin ligand FK506, but not GPI-1046, protects against neuronal death and inhibits c-Jun expression in the substantia nigra pars compacta following transection of the rat medial forebrain bundle.
    Winter C; Schenkel J; Bürger E; Eickmeier C; Zimmermann M; Herdegen T
    Neuroscience; 2000; 95(3):753-62. PubMed ID: 10670442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vulnerability to a Metabolic Challenge Following Perinatal Asphyxia Evaluated by Organotypic Cultures: Neonatal Nicotinamide Treatment.
    Perez-Lobos R; Lespay-Rebolledo C; Tapia-Bustos A; Palacios E; Vío V; Bustamante D; Morales P; Herrera-Marschitz M
    Neurotox Res; 2017 Oct; 32(3):426-443. PubMed ID: 28631256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Potential of L-Type Calcium Channels as a Drug Target for Neuroprotective Therapy in Parkinson's Disease.
    Liss B; Striessnig J
    Annu Rev Pharmacol Toxicol; 2019 Jan; 59():263-289. PubMed ID: 30625283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aquaporin-4 deficiency diminishes the differential degeneration of midbrain dopaminergic neurons in experimental Parkinson's disease.
    Zhang J; Yang B; Sun H; Zhou Y; Liu M; Ding J; Fang F; Fan Y; Hu G
    Neurosci Lett; 2016 Feb; 614():7-15. PubMed ID: 26748031
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mitochondrial Dysfunction Combined with High Calcium Load Leads to Impaired Antioxidant Defense Underlying the Selective Loss of Nigral Dopaminergic Neurons.
    Ricke KM; Paß T; Kimoloi S; Fährmann K; Jüngst C; Schauss A; Baris OR; Aradjanski M; Trifunovic A; Eriksson Faelker TM; Bergami M; Wiesner RJ
    J Neurosci; 2020 Feb; 40(9):1975-1986. PubMed ID: 32005765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GFRalpha-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area.
    Sarabi A; Hoffer BJ; Olson L; Morales M
    J Comp Neurol; 2001 Dec; 441(2):106-17. PubMed ID: 11745638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.